Publication: 703

Publication: 703

Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831

URL

Google Scholar

Citation:: Cancer Res vol 72 (24 supplement) S5

Meeting Instance:: SABCS 2012
Year:: 2012
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Comprehensive
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2194

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: E. H. Romond V. J. Suman J.-H. Jeong G. Sledge C. E. Geyer Jr S. Martino P. Rastogi J. Gralow S. M. Swain E. Winer G. Colon-Otero C. Hudis S. Paik N. E. Davidson E. Mamounas J. Zujewski N. Wolmark E. A. Perez

Networks:

Study: NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: